Literature DB >> 11340288

Human prostate cancer blocks the generation of dendritic cells from CD34+ hematopoietic progenitors.

G V Shurin1, M Aalamian, G Pirtskhalaishvili, S Bykovskaia, E Huland, H Huland, M R Shurin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11340288     DOI： 10.1159/000052584

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  5 in total

1.  Origin and pharmacological modulation of tumor-associated regulatory dendritic cells.

Authors:  Hua Zhong; Dmitriy W Gutkin; Baohui Han; Yang Ma; Anton A Keskinov; Michael R Shurin; Galina V Shurin
Journal:  Int J Cancer       Date:  2014-01-20       Impact factor: 7.396

Review 2.  Tumor associated regulatory dendritic cells.

Authors:  Yang Ma; Galina V Shurin; Dmitriy W Gutkin; Michael R Shurin
Journal:  Semin Cancer Biol       Date:  2012-03-06       Impact factor: 15.707

3.  Type-1 polarized dendritic cells loaded with apoptotic prostate cancer cells are potent inducers of CD8(+) T cells against prostate cancer cells and defined prostate cancer-specific epitopes.

Authors:  Eva Wieckowski; Gurkamal S Chatta; Robbie M Mailliard; William Gooding; Karolina Palucka; Jacques Banchereau; Pawel Kalinski
Journal:  Prostate       Date:  2010-08-17       Impact factor: 4.104

4.  Interferon regulatory factor 8 mediates tumor-induced inhibition of antigen processing and presentation by dendritic cells.

Authors:  Irina L Tourkova; Galina V Shurin; Soldano Ferrone; Michael R Shurin
Journal:  Cancer Immunol Immunother       Date:  2008-08-28       Impact factor: 6.968

5.  Dendritic cells in the cancer microenvironment.

Authors:  Yang Ma; Galina V Shurin; Zhu Peiyuan; Michael R Shurin
Journal:  J Cancer       Date:  2012-12-15       Impact factor: 4.207
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.